Asthma treatment costs the NHS millions each year, with inhalers being a significant part of this expenditure. Dr. Potter highlighted the wide range of inhalers available, from basic bronchodilators ...
Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...
The study that Community Health Center patients, like Cridele, have been participating in seeks to alleviate the strain on rural patients by testing their lung performance at home, with a mobile ...
Drugmaker Viatris beat Wall Street estimates for third-quarter profit and revenue on Thursday, helped by strong demand for its new generic asthma and ADHD drugs, among others, sending its shares up 2.